Correlation Between Effector Therapeutics and INmune Bio
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and INmune Bio, you can compare the effects of market volatilities on Effector Therapeutics and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and INmune Bio.
Diversification Opportunities for Effector Therapeutics and INmune Bio
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Effector and INmune is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and INmune Bio go up and down completely randomly.
Pair Corralation between Effector Therapeutics and INmune Bio
If you would invest 530.00 in INmune Bio on November 4, 2024 and sell it today you would earn a total of 392.00 from holding INmune Bio or generate 73.96% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 5.0% |
Values | Daily Returns |
Effector Therapeutics vs. INmune Bio
Performance |
Timeline |
Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
INmune Bio |
Effector Therapeutics and INmune Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Effector Therapeutics and INmune Bio
The main advantage of trading using opposite Effector Therapeutics and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma | INmune Bio vs. Anixa Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stocks Directory Find actively traded stocks across global markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |